Utilization rates and predictors of sodium glucose cotransporter 2 inhibitor use in patients with heart failure with or without type 2 diabetes.

American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists(2023)

引用 0|浏览1
暂无评分
摘要
Despite guideline recommendations, SGLT2 inhibitors are underutilized in patients with HF with or without T2D.
更多
查看译文
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要